openPR Logo
Press release

2027 Lung Cancer Diagnostics Market Precise Outlook led by GENERAL ELECTRIC COMPANY, Koninklijke Philips, Oncimmune Holdings, OncoCyte Corporation, QIAGEN, Quest Diagnostics

01-30-2019 11:10 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: The Insight Partners

The Insight Partners

The Insight Partners

Lung cancer begins in the lungs, and is basically of two types, known as, small cell lung cancer and non-small cell lung cancer. Lung cancer is largely seen in individuals with smoking habits. It is also considered to be the second leading cause of deaths in the United States. By conducting diagnostic tests within time, it is possible to effectively treat the cancer and also accordingly control the spreading of tumor.

Lung Cancer Diagnostics Market to 2027 - Global Analysis and Forecasts by Test (Sputum Cytology, Biopsy, Imaging, Molecular Test, and Other Tests), Technology (Fluorescent In Situ Hybridization (FISH), Immunohistochemical (IHC), and Other Technologies), and Geography

Key Players operating in the lung cancer diagnosis market include, Abbott, Agilent Technologies, F. Hoffmann-La Roche Ltd, GENERAL ELECTRIC COMPANY, Koninklijke Philips N.V., Oncimmune Holdings Plc, OncoCyte Corporation, QIAGEN, Quest Diagnostics, and Siemens Healthcare GmbH among others.

Get Sample Copy at

Key Benefits-

• To provide detailed information regarding the major factors (drivers, restraints, opportunities, challenges, and trends) influencing the growth of the global Lung Cancer Diagnostics market
• To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa)

Increasing prevalence of lung cancer as well as increase in smoking habits among youth is expected to fuel the growth of the lung cancer diagnosis market during the forecast period. Moreover, the introduction of new and better products by manufacturers is anticipated to offer growth opportunities to the companies in the market.

The "Global Lung Cancer Diagnosis Market Analysis to 2027" is a specialized and in-depth study of the healthcare IT industry with a focus on the global market trend. The report aims to provide an overview of global market with detailed market segmentation by test, technology and geography. The global market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading lung cancer diagnosis market players and offers key trends and opportunities in the market.

Grab Guaranteed Discount at

The global lung cancer diagnosis market is segmented on the basis of test and technology. Based on test, the market is segmented as, sputum cytology, biopsy, imaging, molecular test, and other tests. On the basis of technology, the lung cancer diagnosis market is classified as, fluorescent in situ hybridization (FISH), immunohistochemical (IHC), and other technologies.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global lung cancer diagnosis market based on test and technology. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The lung cancer diagnosis market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the lung cancer diagnosis market in the coming years, owing to rising prevalence of lung cancer cases in the region during the recent years. Asia Pacific is expected to witness significant growth in the market during the forecast period, due to changing lifestyle trends and increase in smoking among the young population.

Buy this Report now at

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Healthcare IT, Biotechnology and Medical Device industries.

Contact us -
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id :

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 2027 Lung Cancer Diagnostics Market Precise Outlook led by GENERAL ELECTRIC COMPANY, Koninklijke Philips, Oncimmune Holdings, OncoCyte Corporation, QIAGEN, Quest Diagnostics here

News-ID: 1545516 • Views: 262

More Releases from The Insight Partners

Global Hand Dryers Market Business Analysis 2020 by CAGR, Share, Revenue and Pro …
With endless progress made in science and technology field, the expertise of the hand dryer industry also looks ahead to grab all positive aspects. The use of hand dryers is heavily spread across the globe and therefore necessary development are taking place at a rapid pace. Due to the continuous rise in the demand for eco-friendly equipment and systems, the hand dryers market is growing. Adoption of hand dryers facilitates paper
2020 Installment Payment Solution Market Growth Opportunities with Key Industry …
Rising adoption of automated and secure installment payment plans for the online business. The increasing conversion rates as well as promotion of higher average tickets as purchase decision-making on high-value items become quick and easier, which is creating lucrative opportunities for the installment payment solution market in the forecast period. Installment Payment Solution Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product Type (Ecommerce Merchants, Brick and Mortar
Allulose Market Insights 2027 - Worldwide Industry Leading Players are Anderson …
Allulose is also known as D-Psicose or D-allulose, and it is a low-calorie monosaccharide sugar. Allulose is commonly used by some major commercial food and beverage manufacturers. Allulose is naturally present in small quantities in certain food items. The sweetness of allulose is estimated to be 70% as compared to the sweetness of sucrose. As of 2018, most commercially available allulose was produced from corn. Food processing companies are using
Image Recognition in CPG Market Outlook to 2027 - COVID-19 Impact and Global Ana …
Image recognition technology, power-driven by machine learning, has been surrounded in several fields, such as self-driving vehicles, automated image organization of visual websites, and face identification on social networking websites. One of the most general image identification applications is social media monitoring, as visual analytics and visual listening are the essential factors of digital marketing. The report includes the profiles of key image recognition in CPG market companies along with their

All 5 Releases

More Releases for Lung

Non Small Cell Lung Cancer Therapeutics Market
The global non-small cell lung cancer therapeutics market is growing impressively due to recent surge in adoption of targeted therapy for treating non-small cell lung cancer. According to a report published by Fortune Business Insights, titled 'Non-Small Cell Lung Cancer Therapeutics: Global Market Analysis, Insights and Forecasts, 2019-2026,' the market value will rise substantially from US$ 16,011.7 Mn in 2018 to US$ 43,713.1 Mn by 2026. Fortune Business Insights has
Interstitial Lung Disease Therapeutics - Pipeline Analysis 2018
Interstitial lung disease is a type of inflammatory disease that affects and thickens the interstitium of the lungs. Download the sample report @ The interstitium is a lace like network of the tissue that provide support to the air sacs and the capillaries in the interstitium which allows the gas exchange between the blood and alveolar tissues. Get the detailed analysis @ Some of the types of the condition include
Lung Cancer and Therapies Meet 2019
Lexis is the world best platform for all the researchers to showcase their on-going research work through Oral/Poster presentations in front of the international audience, provided with additional opportunities for expanding their research work by conducting workshops and by exhibiting products. It gives you the global exposure and helps to associate with the present and potential researchers who discover novel techniques to treat Lung Cancer with different approach. This meet enlightens
Acute Lung Injury Market Technological breakthroughs 2025
Acute lung injury (ALI) is commonly characterized by hypoxia, lung complication and pulmonary edema. This condition causes inflammation or direct injury to the lungs. Generally, the symptoms of this disease are divided into two forms namely, primary ALI and secondary ALI. Primary ALI is caused by the conditions like pneumonia. While, secondary ALI is mainly caused by indirect injury to the lungs. Inhalation injury, pulmonary contusions, sever trauma, shock are
Lung Cancer Treatment Market Outlook to 2022
Market Overview, Key in-line Products, Market Share Distribution, Competitive Dynamics, Regulatory Outlook, Pipeline Development, Growth Catalysts & Challenges, Leading Market & R&D Trends, Partnership & Deals Analyses, Global Sales forecast of in-line and pipeline products, Fast Growing Private Companies, Management Perspectives, Commentaries, Market Outlook & Summary Conclusions The global lung cancer drugs market was valued at $3.1bn in 2016 and is forecast to grow at a healthy 31.1% CAGR between 2016
Europe Lung Cancer Drug Pipeline Analysis
The most common type of cancer in terms of incidence and mortality rate is Lung cancer. Lung cancer is a disease in which the lining of the cell of the lung tissue has an uncontrollable growth which in turn leads to the formation of tumor. There are two main types of lung cancer; small cell lung cancer which accounts for about 20% and non-small cell lung cancer (NSCLC) that accounts